WebMar 31, 2024 · Andrew Dreyfus joined our board of directors in April 2016. Mr. Dreyfus has served as president and chief executive officer for Blue Cross Blue Shield of Massachusetts, or BCBSMA, one of the largest Blue Cross Blue Shield insurance plans in the country, since 2010. From 2005 to 2010, Mr. Dreyfus served as the executive vice president of ... WebApr 21, 2024 · We Are Ironwood NASDAQ: IRWD 10.67 -0.05 (-0.47%) 20 Minute Minimum Delay March 10, 2024 4:00 PM Corporate Overview Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.
Ironwood Pharmaceuticals Eliminates Chief Operating Officer Post
WebIronwood Pharmaceuticals Salaries How much do Ironwood Pharmaceuticals employees make? Glassdoor has salaries, wages, tips, bonuses, and hourly pay based upon employee reports and estimates. Research & Science Based on 35 salaries Senior Associate Scientist 5 salaries Scientist 4 salaries View More Business Based on 20 salaries Director 7 salaries WebMar 5, 2024 · For the twelve months ended December 31st, 2024 vs December 31st, 2016, Ironwood Pharmaceuticals reported revenue of $298.28MM vs $273.96MM (up 8.88%) and basic earnings per share -$0.78 vs -$0.56. philsys correction form online
Ironwood Pharmaceuticals Inc. Cl A - MarketWatch
WebJan 9, 2024 · Ironwood Pharmaceuticals (Nasdaq: IRWD), an S&P SmallCap 600® company, is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine... WebThe Boston Globe named Ironwood Pharmaceuticals a Top Place to Work for 2024, and we have received the Boston’s Middle Market Leader Award for the past two years. Our Flexible and Collaborative Culture We recognize that individuals are essential to Ironwood’s success. Web1 day ago · Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the ... t shirt with name and number on back side